BIOSt® Nematicide Seed Treatment Reduces Greenhouse Gas Emissions in Soybeans and Corn by 85%+ Compared to Conventional Pest...
May 06 2021 - 8:31AM
Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an
international leader in sustainable agricultural biological
solutions, announced today that BIOSt Nematicide seed treatment
product, achieved an outstanding climate impact score of 9.8 out of
10.
The Climate Impact Study showed that BIOSt Nematicide reduced
greenhouse gas (GHG) emissions by 85 percent in soybeans and 87
percent in corn compared with conventional pesticides. The
independent study, conducted by Boundless Impact Research &
Analytics, assessed GHG emissions, human and environmental safety,
and product performance against similar conventional and biological
pesticides used in seed treatment.
BIOSt Nematicide, a novel, broad spectrum biological seed
treatment, was launched in 2016 to protect crops against certain
plant parasitic nematodes and soil-dwelling insect pests. It is
approved for conventional and organic use and is safe for human
use, pollinators (such as bees), and aquatic life. Today, BIOSt
Nematicide is used by an estimated 17,000 growers on more than 11
million acres of row crops in the U.S.
Conservative estimates show that for every million acres of
soybeans and corn seed treated with BIOSt Nematicide, more than one
million pounds of carbon dioxide (CO2) emissions are reduced
respectively. This is equivalent to the amount of carbon
sequestered in one year by nearly 600 acres of U.S. forestland.1 If
BIOSt Nematicide was used on the entire projected 87.6 million U.S.
soybean plantings for 2021, the CO2 emission reduction would
potentially equal more than 43,000 metric tons, comparable to
removing nearly 10,000 passenger cars from the road.
“This study provides further evidence as to the contributions
our products can make toward protecting the environment by reducing
greenhouse gas emissions and providing a safe habitat for
pollinators,” said Kevin Helash, chief executive officer of MBI.
“Biological products now account for roughly one-third of all
active ingredients used in agriculture. Their increasing adoption
has been a testament to their efficacy, safety and sustainability,
and Marrone Bio has been a leader in this growth.”
Helash added, “Sustainability is at the core of our products and
people. This new data underscores the beneficial experience our
distribution partners and grower customers have had with BIOSt
Nematicide in row crops such as soybeans, corn, and cotton. As one
of our flagship products, BIOSt Nematicide provides a unique
solution that delivers effective crop protection and provides
growers with another tool to address the challenges of climate
change.”
These findings support the results of a 2019-2020 GHG life-cycle
assessment conducted by the University of California Davis Graduate
School of Management. This study concluded that the use of MBI’s
bioprotectants would likely reduce GHG emissions by 69 to 91
percent when compared with conventional pesticides. “We strive to
continually assess the environmental impacts of our products in a
fair and factual manner, and both of these studies support that
goal,” said Keith Pitts, chief sustainability officer and senior
vice president of regulatory and government affairs for Marrone
Bio.
Michele Demers, founder and CEO of Boundless Impact Research
& Analytics, said: “Our climate impact assessment of
biopesticides provides a science-based and independent critique and
comparison of the environmental impact of these breakthrough
technologies. BIOSt Nematicide offers a significant environmental
improvement over other conventional pesticides and provides a
compelling alternative.”
BIOSt Nematicide is available throughout the U.S. through
Marrone Bio’s distribution partner, Albaugh LLC, who is the
trademark’s registered owner.
- Research Methodology Overview
Boundless researched the material, energy and performance
characteristics for BIOSt Nematicide based on detailed information
provided by MBI that describes the material components and energy
inputs. At the core of the methodology is a life-cycle assessment
(LCA) model for a kilogram of BIOSt Nematicide. The functional unit
(FU) for this LCA was a million seeds treated with nematicide.
Boundless employed the IPCC 2013 methodology.
About Marrone Bio InnovationsMarrone Bio
Innovations Inc. (NASDAQ: MBII) is a growth-oriented
agricultural company leading the movement to environmentally
sustainable farming practices through the discovery, development
and sale of innovative biological products for crop protection,
crop health and crop nutrition. Our portfolio of more than 15
products helps customers operate more sustainably while increasing
their return on investment. The company’s commercial products are
sold globally and supported by a robust portfolio of more than 500
issued and pending patents. Our end markets include row
crops; fruits and vegetables; trees, nuts and vines; and greenhouse
production. The Company’s research and development program uses
proprietary technologies to isolate and screen naturally occurring
microorganisms and plant extracts to create new, environmentally
sound solutions in agriculture. For more information, please visit
the Company’s website at marronebio.com.
Learn more about Marrone Bio Innovations
at www.marronebio.com. We also use our investor relations
website, https://investors.marronebio.com, as well as our
corporate Twitter account, @Marronebio, as means of disclosing
material non-public information, and encourage our investors and
others to monitor and review the information we make public in
these locations. Follow us on social
media: Twitter, LinkedIn and Instagram.
Marrone Bio Innovations Forward Looking
StatementsThis press release contains forward-looking
statements that involve substantial risks and uncertainties. All
statements, other than statements of historical facts, included in
this press release regarding strategy, future operations and plans,
including assumptions underlying such statements, are
forward-looking statements, and should not be relied upon as
representing MBI’s views as of any subsequent date. Such
forward-looking statements are based on information available to
the Company as of the date of this release and involve a number of
risks and uncertainties, some beyond the Company’s control, that
could cause actual results to differ materially from those
anticipated by these forward-looking statements, including,
regulatory and other factors affecting demand for the MBI’s
products, any difficulty in marketing MBI’s products in its target
markets, competition in the market for pest management products,
lack of understanding of bio-based pest management products by
customers and growers. Additional information that could lead to
material changes in MBI’s performance is contained in its filings
with the SEC. MBI is under no obligation to, and expressly
disclaims any responsibility to, update or alter forward-looking
statements contained in this release, whether as a result of
current information, future events or otherwise.
Marrone Bio Innovations Contact:Clyde
MontevirgenVice President of Business Development & Investor
RelationsTelephone: 530-750-2800info@marronebio.com
Investor Relations:Lucas A. ZimmermanSenior
Vice PresidentMZ Group – MZ North AmericaMain: 949-259-4987
MBII@mzgroup.us
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Mar 2024 to Apr 2024
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Apr 2023 to Apr 2024